Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$213 Hold
2
﹤0.01% 669
2022
Q1
$215 Hold
2
﹤0.01% 959
2021
Q4
$242 Sell
2
-460
-100% -$55.4K ﹤0.01% 827
2021
Q3
$55.3K Hold
462
0.01% 609
2021
Q2
$66.1K Buy
462
+220
+91% +$30.1K 0.02% 602
2021
Q1
$33.3K Buy
242
+240
+12,000% +$31.9K 0.01% 542
2020
Q4
$239 Sell
2
-37
-95% -$3.68K ﹤0.01% 789
2020
Q3
$3.23K Sell
39
-500
-93% -$42.6K ﹤0.01% 535
2020
Q2
$41.9K Hold
539
0.01% 365
2020
Q1
$33K Hold
539
0.01% 387
2019
Q4
$42.7K Sell
539
-9,725
-95% -$692K 0.01% 361
2019
Q3
$700K Sell
10,264
-4,348
-30% -$318K 0.13% 129
2019
Q2
$1.31M Sell
14,612
-9,273
-39% -$831K 0.23% 91
2019
Q1
$2.2M Sell
23,885
-5,263
-18% -$466K 0.44% 66
2018
Q4
$2.42M Buy
29,148
+641
+2% +$56.3K 0.43% 69
2018
Q3
$3.03M Buy
28,507
+1,932
+7% +$189K 0.57% 53
2018
Q2
$2.49M Sell
26,575
-898
-3% -$77.7K 0.42% 46
2018
Q1
$2.12M Buy
27,473
+6,058
+28% +$442K 0.42% 61
2017
Q4
$1.3M Buy
+21,415
New +$1.33M 0.22% 82

Other funds holding PTC

Exane Derivatives's PTC Position: Q2 2022 in Review

Exane Derivatives held its PTC (PTC) position steady in Q2 2022 at 2 shares worth $213. The position accounts for ﹤0.01% of the portfolio, ranked #669.

Exane Derivatives first reported a position in PTC in Q4 2017 and has held it in 19 quarters since. The position peaked at $3.03M in Q3 2018. 479 funds tracked by Wall St. Rank hold PTC as of Q2 2022.

  • Exane Derivatives held 2 shares of PTC worth $213 as of Q2 2022.
  • Exane Derivatives left its PTC share count unchanged in Q2 2022.
  • PTC made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #669 holding.
  • Exane Derivatives first reported a position in PTC in Q4 2017 and has held it in 19 quarters since.
  • Exane Derivatives's PTC position peaked at $3.03M in Q3 2018.
  • 479 funds tracked by Wall St. Rank held PTC as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.